The report is dated "31 July 2020" on page 1 so this has been a work in progress for at least 3 months.
Phase I: Wuhan may not have been where the outbreak started; we need to examine the Dec 2019 cases to see if there are links to other parts of China and other countries.
Current knowledge: "the virus has been remarkable stable since it was first reported in Wuhan, with sequences well conserved in different countries, suggesting that the virus was well adapted to human transmission from the moment it was first detected."
Thank you for the validation @WHO You can't imagine the chaos @shingheizhan and I experienced in May this year for using the phrase "well adapted" in our preprint. biorxiv.org/content/10.110…
More current knowledge: "Two of the genetically closest known coronaviruses, RaTG13 and RmYN02, were discovered in bat populations in Yunnan province of China"
Did you also know that RaTG13 came from a mine where 6 miners came down with a SARS-like illness in 2012 and 3 died?
I am relieved that the @WHO report did not cite the two pangolin CoV papers with data issues (Xiao et al. @Nature and Liu et al. @PLoSPathogens). Instead, @WHO decided to cite the Proximal Origins correspondence to mention the RBD similarity between the GD pangolin CoV and SARS2.
At least the @WHO current knowledge is honest: "there is no evidence to demonstrate the possible route of transmission from a bat reservoir to human through one or several intermediary animal species"
In other words, no evidence for natural spillover.
On animal reservoirs: "different animal species in regular contacts with humans are susceptible to infection with SARS-CoV-2 and could serve as intermediate animal host species or could establish new reservoirs for the virus and new sources for spill-over"
On food and surfaces: "Recent outbreaks in markets as well as food processing plants.. have raised questions about the potential role of food products as a vehicle of transmission.. But there is no evidence that contaminated food items may have contributed to transmission."
On the first cases of COVID in Wuhan: "The early cases in Wuhan are thought to have occurred in early December.. little is currently known about how, where and when the virus started circulation in Wuhan. Preliminary studies have not generated credible leads..."
Phase 1 Epidemiological study:
Review hospital records pre-December.
Review disease/mortality trends compared to previous years.
Interview early cases.
Serological studies on banked blood samples collected pre-December.
Major problem: the @WHO team is not allowed to perform this investigation. They only get to review the report generated by Chinese scientists.
More on Phase 1 wrt animals/food products: Activities and traded animals/goods, as well as supply chains pertaining to the Huanan market will be extensively mapped.
"the study will therefore build on existing information and augment, rather than duplicate, ongoing or existing efforts"
That's a nice way of saying that you cannot perform the investigation yourself. You can only build on what China will tell you.
Phase 2. Potential venues of investigation.
Checking more people and animals in other locations that could have been the origin of SARS2.
Basically, this report only has a Phase 1.
On to the best part. Who is on the @WHO international team?
"The final composition of the international team should be agreed by both China and WHO."
I don't even get to pick my peer reviewers. But China gets to pick the @WHO investigation team?
Thanks @WHO I haven't laughed and cried so hard simultaneously for many years.
I'm sad because it looks like the @WHO does not have the power to perform a truly independent investigation. Lab escape was not even mentioned in this report which took them 3 months to write.
I couldn't resist doing a hot take on the @WHO SARS-CoV-2 origins investigation meeting report, but after I recover from reading this, I will try to generate a list of questions that non-China-approved independent parties can actually investigate without having to go into China.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
It relates to the curiosity of all of these #pangolinpapers being released on Feb 18-20, driving a mania that SARS2 came from pangolins; all 4 papers used the same 2019 dataset; there is a web of co-authorship (scroll to end of the thread cited here):
I'm saving a 🔥🐉 thread on the issues in these papers for when their corrections are issued. But key questions raised by @USRightToKnow (I'm paraphrasing):
1. Did these authors know about each other preprinting in the same 3 days (3 groups on Feb 20, 1 group on Feb 18)?
After vaccines are developed, there are still hurdles to returning to normal. (1) Vaccination compliance; if few people are vaccinated, this doesn't result in herd immunity. Some individuals also don't develop lasting immunity in response to the vaccine... vaccinestoday.eu/stories/why-do…
Let's say only a 50% of states have widespread vaccination, you'll still have to think about interstate & international travel in terms of whether you're traveling to a place where there is no herd immunity and the risks of you getting sick there even if you have been vaccinated.
Thorough article by @GMWatch about the conflict of interest and lack of accurate information coming from EcoHealth on the topic of SARS2 origins - but you forgot to mention the karaoke parties and spelunking parties...
Please do not allow EcoHealth to visit any more bat caves. The last thing we need is SARS2 being accidentally given to bats in the wild (like the mink farms). Bats already have a great virus reservoir going on, no need to add human viruses with novel features to their inventory.
On the SARS2 mink outbreak in Denmark: "genome sequences of human and animal strains will continue to facilitate detailed analyses by partners... WHO... are working with Danish scientists to better understand the available results" who.int/csr/don/06-nov…
However, no Danish mink SARS2 sequences are publicly available yet. (Please let me know if it becomes available!) So it's tough to tell exactly which SARS2 mutation combos to be looking at.
Regardless, ending mink farming is a good preemptive move to reduce covid outbreak risk.
One reason why the Danish PM decided on mink culling was that "this particular mink-associated variant identified in both minks and the 12 human cases has moderately decreased sensitivity to neutralizing antibodies."
Raising concerns about vaccine efficacy against the mink SARS2.
Maybe @WHO forgot, but in 2004, the intermediate host of SARS was found within a week of diagnosing an index patient. When you know what to look for, it doesn't necessarily take years.
"When possible SARS was diagnosed in the waitress on January 2, 2004, serum, throat and rectal swabs were obtained from all 6 palm civets at the restaurant... Serum samples from employees of the restaurant were obtained on January 4." ncbi.nlm.nih.gov/pmc/articles/P…
Yes, in the past, tracing some outbreaks could take years because people had no idea what they were looking for - which species could have been the intermediate host or the ultimate virus reservoir (bats). But China already developed extensive know-how from the SARS1 outbreak...
On the topic of controversial SARS2 mutations. I've been delaying a thread on D614G because I think people watching US elections do not have the emotional/mental bandwidth to deal with complex analyses.
But it looks like the election results won't be known for days, so...
How does the D614G variant affect public health measures, vaccines, and therapeutics?
As far as we know - there is no impact.
The paper claiming that it increases transmissibility, says: "no significant correlation found between D614G status and hospitalization status"
Furthermore, the D614G mutant has been one of the earliest variants in each country (except China and a few exceptions) since the beginning - it's not like this strain suddenly appeared later in the pandemic - covered in this thread: